Abstract
Objective
To assess the relationship between yogurt intake and mortality risk from prospective cohort studies.
Methods
The PubMed, EMBASE, and Web of Science databases were searched for all records related to yogurt intake and mortality risk [all-cause or cardiovascular disease (CVD) or cancer mortality] before October 1, 2018. The Newcastle-Ottawa Quality Scale was used to estimate the quality of all eligible articles. The results of the highest and lowest categories of yogurt intake in each study were collected and the effect size was pooled using a random effects model. The dose-response analysis was calculated using the generalized least squares trend estimation model.
Results
Eight eligible cohort studies were included in this meta-analysis. There were 235,676 participants in the 8 studies, and the number of deaths was 14,831. Compared with the lowest category, the highest category of yogurt intake was not significantly related with all-cause mortality [hazard ratio (HR)=0.93; 95% confidence interval (CI): 0.85, 1.01], CVD mortality (HR=0.92; 95% CI: 0.81, 1.03) and cancer mortality (HR=0.97; 95% CI: 0.83, 1.12). These studies were homogenous, since the homogeneity test showed that I2 was 28.7%, 15.1% and 11.8%, respectively. However, yogurt intake ⩾200 g/d was significantly associated with a lower all-cause mortality (HR=0.88; 95% CI: 0.80, 0.96) and CVD mortality (HR=0.87; 95% CI: 0.77, 0.99) in the subgroup analysis. The dose-response analysis showed that yogurt intake of 200 g/d was inversely associated with all-cause mortality (P=0.041, HR=0.95, 95% CI: 0.92, 1.00) and CVD mortality (P=0.009, HR=0.92, 95% CI: 0.86, 0.98), and all of which were linear relationship (P>0.05).
Conclusions
This review provided the evidence regarding yogurt intake can reduce all-cause and CVD mortality. Although some positive findings were identified, more high-quality cohort studies and randomized controlled trials are warranted on a possible protective effect of yoghurt on health.
Similar content being viewed by others
References
Fisberg M, Machado R. History of yogurt and current patterns of consumption. Nutr Rev 2015;73 Suppl 1:4–7.
Webb D, Donovan SM, Meydani SN. The role of yogurt in improving the quality of the American diet and meeting dietary guidelines. Nutr Rev 2014;72:180–189.
Wang H, Livingston KA, Fox CS, Meigs JB, Jacques PF. Yogurt consumption is associated with better diet quality and metabolic profile in American men and women. Nutr Res 2013;33:18–26.
Kong LC, Holmes BA, Cotillard A, Habi-Rachedi F, Brazeilles R, Gougis S, et al. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS One 2014;9:e109434.
Cormier H, Thifault E, Garneau V, Tremblay A, Drapeau V, Pérusse L, et al. Association between yogurt consumption, dietary patterns, and cardio-metabolic risk factors. Eur J Nutr 2016;55:577–587.
Zhu Y, Wang H, Hollis JH, Jacques PF. The associations between yogurt consumption, diet quality, and metabolic profiles in children in the USA. Eur J Nutr 2015;54:543–550.
Tong X, Dong JY, Wu ZW, Li W, Qin LQ. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr 2011;65:1027–1031.
Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, et al. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One 2013;8:e73965.
Bonthuis M, Hughes MCB, Ibiebele TI, Green AC, van der Pols JC. Dairy consumption and patterns of mortality of Australian adults. Eur J Clin Nutr 2010;64:569–577.
Tseng WT, Shih TW, Liu SH, Pan TM. Safety and mutagenicity evaluation of Vigiis 101 powder made from Lactobacillus paracasei subsp paracasei NTU 101. Regul Toxicol Pharm 2015;71:148–157.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008–2012.
Zelaya H, Alvarez S, Kitazawa H, Villena J. Respiratory antiviral immunity and immunobiotics: beneficial effects on inflammation-coagulation interaction during influenza virus infection. Front Immunol 2016;7:633.
Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006;6:40–57.
Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175:66–73.
Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 2014;37:569–586.
Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Brit J Nutr 2013;109:718–726.
Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, et al. Dairy food intake and all-cause, cardiovascular disease, and cancer mortality: the Golestan cohort study. Am J Epidemiol 2017;185:697–711.
Dik VK, Murphy N, Siersema PD, Fedirko V, Jenab M, Kong SY, et al. Prediagnostic intake of dairy products and dietary calcium and colorectal cancer survival-results from the EPIC cohort study. Cancer Epidem Biomar 2014;23:1813–1823.
Praagman J, Dalmeijer GW, van der Schouw YT, Soedamah-Muthu SS, Monique Verschuren WM, Bas Bueno-de-Mesquita H, et al. The relationship between fermented food intake and mortality risk in the European prospective investigation into cancer and nutrition-Netherlands cohort. Brit J Nutr 2015;113:498–506.
Dehghan M, Mente A, Rangarajan S, Sheridan P, Mohan V, Iqbal R, et al. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet 2018;392:2288–2297.
Bongard V, Arveiler D, Dallongeville J, Ruidavets JB, Wagner A, Simon C, et al. Food groups associated with a reduced risk of 15-year all-cause death. Eur J Clin Nutr 2016;70:715–722.
Matsumoto M, Ishikawa S, Nakamura Y, Kayaba K, Kajii E. Consumption of dairy products and cancer risks. J Epidemiol 2007;17:38–44.
Guo J, Astrup A, Lovegrove JA, Gijsbers L, Givens DI, Soedamah-Muthu SS. Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol 2017;32:269–287.
Lu W, Chen H, Niu Y, Wu H, Xia D, Wu Y. Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based cohort studies. Nutr J 2016;15:91.
Panahi S, Tremblay A. The potential role of yogurt in weight management and prevention of type 2 diabetes. J Am Coll Nutr 2016;35:717–731.
Park SY, Seong KS, Lim SD. Anti-obesity effect of yogurt fermented by Lactobacillus plantarum Q180 in diet-induced obese rats. Korean J Food Sci An 2016;36:77–83.
Jauhiainen T, Korpela R. Milk peptides and blood pressure. J Nutr 2007;137:825S–829S.
Severin S, Xia WS. Milk biologically active components as nutraceuticals: review. Crit Rev Food Sci 2005;45:645–656.
Dong J-Y, Szeto IMY, Makinen K, Gao Q, Wang J, Qin LQ, et al. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Brit J Nutr 2013;110:1188–1194.
Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr 2000;54:856–860.
Sun J, Buys N. Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials. Ann Med 2015;47:430–440.
Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010;5:e9085.
Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Design 2009;15:1546–1558.
Larsson SC, Crippa A, Orsini N, Wolk A, Michaelsson K. Milk consumption and mortality from all causes, cardiovascular disease, and cancer: a systematic review and meta-analysis. Nutrients 2015;7:7749–7763.
Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, Willett WC, et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr 2011;93:158–171.
O’Sullivan TA, Hafekost K, Mitrou F, Lawrence D. Food sources of saturated fat and the association with mortality: a meta-analysis. Am J Public Health 2013;103:E31–E42.
Cui Y, Huang C, Momma H, Ren Z, Sugiyama S, Guan L, et al. Consumption of low-fat dairy, but not whole-fat dairy, is inversely associated with depressive symptoms in Japanese adults. Soc Psych Psych Epid 2017;52:847–853.
Alonso A, Zozaya C, Vazquez Z, Alfredo Martinez J, Martinez-Gonzalez MA. The effect of low-fat versus whole-fat dairy product intake on blood pressure and weight in young normotensive adults. J Hum Nutr Diet 2009;22:336–342.
Author information
Authors and Affiliations
Contributions
Gao X was mainly responsible for research design, implementation and article writing; Jia HY contributed to literature search and review; Chen GC and Li CY contributed to modify the article; Hao M provided technical guidance.
Corresponding author
Ethics declarations
The authors declare no conflict of interest.
Additional information
Supported by the Shanghai Three-Year Action Plan for Strengthening Public Health System Construction (2015–2017) (No. GWIV-32)
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Gao, X., Jia, Hy., Chen, Gc. et al. Yogurt Intake Reduces All-Cause and Cardiovascular Disease Mortality: A Meta-Analysis of Eight Prospective Cohort Studies. Chin. J. Integr. Med. 26, 462–468 (2020). https://doi.org/10.1007/s11655-020-3085-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-020-3085-8